UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000035661
Receipt number R000040623
Scientific Title The effect of postoperative analgesia for post operative oxygenation in patients with interstitial pneumonia undergoing surgical biopasy
Date of disclosure of the study information 2019/01/25
Last modified on 2019/11/25 20:45:51

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effect of postoperative analgesia for post operative oxygenation in patients with interstitial pneumonia undergoing surgical biopasy

Acronym

The effect of postoperative analgesia for post operative oxygenation in patients with interstitial pneumonia undergoing surgical biopasy

Scientific Title

The effect of postoperative analgesia for post operative oxygenation in patients with interstitial pneumonia undergoing surgical biopasy

Scientific Title:Acronym

The effect of postoperative analgesia for post operative oxygenation in patients with interstitial pneumonia undergoing surgical biopasy

Region

Japan


Condition

Condition

Inetrstitial Pneumonia

Classification by specialty

Anesthesiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is investigating the association betweeen postoperative analgesia (epidural anesthesia or intercostal nerve block) and postoperative oxygenation in patients with interstitial pneumonia undergoing surgical biopsy.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Not applicable


Assessment

Primary outcomes

The rate of oxygen independent patients in each analgesia group.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Epidural anesthesia with continuous infusion of 0.2% ropivacaine.

Interventions/Control_2

Intra operative sigle shot 0.375% ropivacaine as intercostal nerve block and postoperative continuous intravenous infusion of fentanyl.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Adult patients undergoing surgical lung biopsy for interstitial pneumonia, who admit to ICU after the opration.

Key exclusion criteria

Exclusion criteria:1) Patients who have contraindications to epidural anesthesia, 2) Patients underwent home oxygen therapy before the operation, 3) Patients who admit to ICU under tracheal intubation and mechanical ventilation.

Target sample size

70


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Masahiro Gamo

Organization

Kanagawa Cardiovascular and Respiratory Center

Division name

Department of Anesthesiology

Zip code


Address

6-16-1, Tomiokahigashi, Kanazawa-ku Yokohama-shi, Kanagawa, Japan

TEL

045-701-9581

Email

gamou@kanagawa-junko.jp


Public contact

Name of contact person

1st name
Middle name
Last name Natsuhiro Yamamoto

Organization

Yokohama City University

Division name

Department of Anesthesiology

Zip code


Address

3-9, Fukuura, Kanazawa-ku Yokohama-shi, Kanagawa, Japan

TEL

045-787-2918

Homepage URL


Email

natsuyamamo@gmail.com


Sponsor or person

Institute

Kanagawa Cardiovascular and Respiratory Center

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

神奈川県立循環器呼吸器病センター


Other administrative information

Date of disclosure of the study information

2019 Year 01 Month 25 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2019 Year 01 Month 24 Day

Date of IRB

2018 Year 10 Month 15 Day

Anticipated trial start date

2019 Year 01 Month 24 Day

Last follow-up date

2019 Year 11 Month 25 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 01 Month 24 Day

Last modified on

2019 Year 11 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040623


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name